摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(2-Methoxyphenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde | 139359-77-6

中文名称
——
中文别名
——
英文名称
6-(2-Methoxyphenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde
英文别名
——
6-(2-Methoxyphenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde化学式
CAS
139359-77-6
化学式
C13H10N2O2S
mdl
——
分子量
258.301
InChiKey
VUZBEWQLMCHEEJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    71.8
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    6-(2-Methoxyphenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde乙酰乙酸甲酯ammonium hydroxide 作用下, 以 异丙醇 为溶剂, 以10%的产率得到Dimethyl 4-[6-(2-methoxyphenyl)imidazo[2,1-b][1,3]thiazol-5-yl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
    参考文献:
    名称:
    Imidazo[2,1-b]thiazole System: A Scaffold Endowing Dihydropyridines with Selective Cardiodepressant Activity
    摘要:
    The synthesis, characterization, and functional in vitro assays in cardiac tissues and smooth muscle (vascular and nonvascular) of a number of 4-imidazo[2,1-b]thiazole-1,4-dihydropyridines are reported. The binding properties for the novel compounds have been investigated and the interaction with the binding site common to other aryl-dihydropyridines has been demonstrated. Interestingly, the novel 4-aryl-dihydropyridines are L-type calcium channel blockers with a peculiar pharmacological behavior. Indeed, the imidazo[2,1-b]thiazole system is found to confer to the dihydropyridine scaffold an inotropic and/or chronotropic cardiovascular activity with a high selectivity toward the nonvascular tissue. Finally, molecular modeling studies were undertaken for the most representative compounds with the aim of describing the binding properties of the new ligands at molecular level and to rationalize the found structure-activity relationship data. Due to the observed pharmacological behavior of our compounds, they might be promising agents for the treatment of specific cardiovascular pathologies such as cardiac hypertrophy and ischemia.
    DOI:
    10.1021/jm070681+
点击查看最新优质反应信息